Previous close | 0.7300 |
Open | 0.7300 |
Bid | 0.2500 |
Ask | 1.1000 |
Strike | 23.00 |
Expiry date | 2023-02-17 |
Day's range | 0.7300 - 0.7300 |
Contract range | N/A |
Volume | |
Open interest | 510 |
In this article we are going to estimate the intrinsic value of Corcept Therapeutics Incorporated ( NASDAQ:CORT ) by...
Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since approval. However, sole dependence on Korlym for revenues remains a headwind.
Durect (DRRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.